Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1772
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


A meta-analysis of bevacizumab combined with chemotherapy in the treatment of ovarian cancer

Wang T S, Lei W, Cui W, Wen P, Guo H F, Ding S G, Yang Y P, Xu Y Q, Lv S W, Zhu Y L

Year : 2014| Volume: 51| Issue : 7 | Page no: 95-98

   This article has been cited by
1 Risk of Thrombo-Embolic Events in Ovarian Cancer: Does Bevacizumab Tilt the Scale? A Systematic Review and Meta-Analysis
Michael Saerens, Emiel A. De Jaeghere, Heini Kanervo, Nele Vandemaele, Hannelore Denys, Eline Naert
Cancers. 2021; 13(18): 4603
[Pubmed]  [Google Scholar] [DOI]
2 A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer
Liina Salminen, Nimrah Nadeem, Shruti Jain, Seija Grènman, Olli Carpén, Sakari Hietanen, Sinikka Oksa, Urpo Lamminmäki, Kim Pettersson, Kamlesh Gidwani, Kaisa Huhtinen, Johanna Hynninen
Gynecologic Oncology. 2020; 156(3): 689
[Pubmed]  [Google Scholar] [DOI]
3 Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews
Marina T Van Leeuwen, Steven Luu, Howard Gurney, Martin R Brown, Sallie-Anne Pearson, Kate Webber, Lee Hunt, Soojung Hong, Geoffrey P Delaney, Claire M Vajdic
JNCI Cancer Spectrum. 2020; 4(6)
[Pubmed]  [Google Scholar] [DOI]
4 Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
Chi-Kang Lin, Meng-Yi Bai, Teh-Min Hu, Yu-Chi Wang, Tai-Kuang Chao, Shao-Ju Weng, Rui-Lan Huang, Po-Hsuan Su, Hung-Cheng Lai
Oncotarget. 2016; 7(8): 8993
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow